26 results
Medium Risk Aspirin Decision Aid for Primary Cardiovascular Prevention - MEDIUM / ELEVATED risk (range low
Decision Aid for Primary ... Cardiovascular Prevention ... elevated - high) #Management ... #PatientInfo #ElevatedRisk ... MediumRisk #Moderate #HeartAttack
High Risk Aspirin Decision Aid for Primary Cardiovascular Prevention - HIGH risk (range low - elevated
Decision Aid for Primary ... Cardiovascular Prevention ... elevated - high) #Management ... #PatientInfo #HighRisk ... #HeartAttack #Bleeding
Low Risk Aspirin Decision Aid for Primary Cardiovascular Prevention - LOW / AVERAGE risk (range low
Decision Aid for Primary ... Cardiovascular Prevention ... elevated - high) #Management ... #PatientInfo #LowRisk ... #AverageRisk #HeartAttack
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Penicilliosis #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... HumanPapillomavirus #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... for Preventing ... Trypanosomiasis #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... for Initiating Primary ... opportunistic #infections #HIVAIDS ... #management #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... Enteric #Bacterial #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... candida #mucosal #IDSA ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... Sarcoma (KS), Primary ... KaposiSarcoma #Castlemans #IDSA ... #management #opportunistic ... #infections #HIVAIDS